FI873059A0 - Insprutningsfaerdig, vattenhaltig, alkalisk injektionsloesning av torasemid och foerfarande foer framstaellning av densamma. - Google Patents

Insprutningsfaerdig, vattenhaltig, alkalisk injektionsloesning av torasemid och foerfarande foer framstaellning av densamma.

Info

Publication number
FI873059A0
FI873059A0 FI873059A FI873059A FI873059A0 FI 873059 A0 FI873059 A0 FI 873059A0 FI 873059 A FI873059 A FI 873059A FI 873059 A FI873059 A FI 873059A FI 873059 A0 FI873059 A0 FI 873059A0
Authority
FI
Finland
Prior art keywords
torasemide
insprutningsfaerdig
injektionsloesning
alkalisk
torasemid
Prior art date
Application number
FI873059A
Other languages
English (en)
Other versions
FI87993C (fi
FI87993B (fi
FI873059A (fi
Inventor
Fritz Demmer
Werner Gruber
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI873059A0 publication Critical patent/FI873059A0/fi
Publication of FI873059A publication Critical patent/FI873059A/fi
Application granted granted Critical
Publication of FI87993B publication Critical patent/FI87993B/fi
Publication of FI87993C publication Critical patent/FI87993C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ink Jet (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pyridine Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FI873059A 1986-07-12 1987-07-10 Foerfarande foer framstaellning av alkaliska injektionsloesningar av torasemid innehaollande vatten, som aer faerdiga foer injicering FI87993C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3623620 1986-07-12
DE19863623620 DE3623620A1 (de) 1986-07-12 1986-07-12 Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung

Publications (4)

Publication Number Publication Date
FI873059A0 true FI873059A0 (fi) 1987-07-10
FI873059A FI873059A (fi) 1988-01-13
FI87993B FI87993B (fi) 1992-12-15
FI87993C FI87993C (fi) 1993-03-25

Family

ID=6305087

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873059A FI87993C (fi) 1986-07-12 1987-07-10 Foerfarande foer framstaellning av alkaliska injektionsloesningar av torasemid innehaollande vatten, som aer faerdiga foer injicering

Country Status (13)

Country Link
US (1) US4861786A (fi)
EP (1) EP0253226B1 (fi)
JP (1) JPS6323818A (fi)
KR (1) KR950010158B1 (fi)
AT (1) ATE53296T1 (fi)
AU (1) AU578562B2 (fi)
CA (1) CA1302278C (fi)
DE (2) DE3623620A1 (fi)
DK (1) DK174624B1 (fi)
ES (1) ES2016306B3 (fi)
FI (1) FI87993C (fi)
GR (1) GR3000534T3 (fi)
NZ (1) NZ221026A (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486530A (en) * 1991-04-27 1996-01-23 Boehringer Mannheim Gmbh Use of torasemide for the treatment of brain oedemas
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
JP3028171B2 (ja) * 1993-08-31 2000-04-04 日本ピラー工業株式会社 複合ガスケット
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US6228873B1 (en) 1994-12-09 2001-05-08 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
US5763491A (en) * 1994-12-09 1998-06-09 The Regents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
MXPA02001369A (es) 1999-08-11 2005-08-26 Teva Pharma Torasemidas polimorfas.
SK14802002A3 (sk) 2000-03-20 2003-05-02 Teva Pharmaceutical Industries Ltd. Nový spôsob prípravy medziproduktu torsemidu
EP1465596A1 (en) * 2002-01-18 2004-10-13 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
US20100053852A1 (en) * 2008-09-02 2010-03-04 Cheng Uei Precision Industry Co., Ltd. Display Device
CN103371967A (zh) * 2012-04-17 2013-10-30 上海禾丰制药有限公司 呋塞米注射液及其制剂工艺
US9884039B2 (en) * 2013-04-05 2018-02-06 Scpharmaceuticals Inc. Pharmaceutical formulations for subcutaneous administration of furosemide
FR3077984B1 (fr) 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
WO2020160210A1 (en) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
CN110606826B (zh) * 2019-05-23 2021-06-01 上海勋和医药科技有限公司 托拉塞米钠一水合物、其晶型及组合物
CN112168776B (zh) * 2020-10-30 2022-05-03 康普药业股份有限公司 一种低杂质高稳定的托拉塞米注射液和制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE185374C (fi) *
DE30681C (de) * R.W. traylor in Richmond, County of Henrico State of Virginia, V. St. A Gufsform aus Glimmer
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
DE3241765A1 (de) * 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid

Also Published As

Publication number Publication date
CA1302278C (en) 1992-06-02
DE3763010D1 (de) 1990-07-12
DE3623620C2 (fi) 1991-02-28
DE3623620A1 (de) 1988-01-21
ES2016306B3 (es) 1990-11-01
DK360287A (da) 1988-01-13
ATE53296T1 (de) 1990-06-15
EP0253226B1 (de) 1990-06-06
DK360287D0 (da) 1987-07-10
AU578562B2 (en) 1988-10-27
KR880001294A (ko) 1988-04-22
FI87993C (fi) 1993-03-25
GR3000534T3 (en) 1991-07-31
FI87993B (fi) 1992-12-15
US4861786A (en) 1989-08-29
FI873059A (fi) 1988-01-13
NZ221026A (en) 1989-09-27
KR950010158B1 (ko) 1995-09-11
EP0253226A1 (de) 1988-01-20
JPS6323818A (ja) 1988-02-01
JPH055810B2 (fi) 1993-01-25
AU7535587A (en) 1988-01-14
DK174624B1 (da) 2003-07-28

Similar Documents

Publication Publication Date Title
FI873059A (fi) Insprutningsfaerdig, vattenhaltig, alkalisk injektionsloesning av torasemid och foerfarande foer framstaellning av densamma.
NO166687C (no) Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.
KR920003971A (ko) 점안액 조성물
KR830008490A (ko) 시클릭 펩타이드의 제조방법
EA199600024A2 (ru) Жидкая стабильная фармацевтическая композиция, содержащая уратоксидазу и лиофилизат для ее получения
KR890006644A (ko) 결정성 β-락탐 수화물
ATE65084T1 (de) Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen.
ES2062015T3 (es) Soluciones inyectables.
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
DE59108859D1 (de) 3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel
KR860002269A (ko) 비경구용 액제의 제조방법
GB1286978A (en) Disinfectant compositions
DE3685712D1 (de) Dermatica.
FI935611A (fi) Foerfarande foer framstaellning av suppositorier genom sammanpressning och med foerfarandet erhaollna suppositorier
TH4330EX (th) สารผสมประเภทซักล้างชนิดเหลว

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BOEHRINGER MANNHEIM GMBH

MA Patent expired